Medtronic Symplicity renal denervation shows significant blood pressure drops in real-world study; FDA approves labeling update

Medtronic reported six-month data from the SPYRAL AFFIRM study showing significant blood pressure reductions with its Symplicity Spyral renal denervation system. The FDA also approved a labeling update adding clinical data for broader patient populations, supporting the device's commercial adoption.